Search research articles
Contact Us
Filters
Showing results (51-60 of 75) with videos related to
Page
of 8
Sort By:
Genes
|
May 28, 2022
Reduction of <i>BMPR2</i> mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth, et al.
ESC Heart Failure
|
June 16, 2022
Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
Max Wissmüller, Panagiota Xanthouli, Nicola Benjamin, et al.
Arthritis Research & Therapy
|
March 9, 2023
Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
Panagiota Xanthouli, Ojan Gordjani, Nicola Benjamin, et al.
Pharmacological Research
|
November 7, 2016
Gender-related differences in pulmonary arterial hypertension targeted drugs administration
Alberto M Marra, Nicola Benjamin, Christina Eichstaedt, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, et al.
International Journal of Molecular Sciences
|
May 14, 2020
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study
Christina A Eichstaedt, Jeremias Verweyen, Michael Halank, et al.
Annals of the Rheumatic Diseases
|
December 17, 2020
Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>
Ekkehard Grünig, Nicola Benjamin, Panagiota Xanthouli, et al.
Pneumologie (Stuttgart, Germany)
|
October 6, 2025
[General Measures and Management of PAH in Special Conditions]
Mona Lichtblau, Satenik Harutyunova, Hans Klose, et al.
Arthritis Research & Therapy
|
October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
International Journal of Cardiology
|
September 8, 2018
General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 75) with videos related to
Sort By:
Page
of 8
Genes
|
May 28, 2022
Reduction of <i>BMPR2</i> mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
Vivienne Theobald, Nicola Benjamin, Hans-Jürgen Seyfarth, et al.
ESC Heart Failure
|
June 16, 2022
Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres
Max Wissmüller, Panagiota Xanthouli, Nicola Benjamin, et al.
Arthritis Research & Therapy
|
March 9, 2023
Hypochromic red cells as a prognostic indicator of survival among patients with systemic sclerosis screened for pulmonary hypertension
Panagiota Xanthouli, Ojan Gordjani, Nicola Benjamin, et al.
Pharmacological Research
|
November 7, 2016
Gender-related differences in pulmonary arterial hypertension targeted drugs administration
Alberto M Marra, Nicola Benjamin, Christina Eichstaedt, et al.
Annals of the Rheumatic Diseases
|
December 11, 2019
Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension
Panagiota Xanthouli, Suzana Jordan, Nicklas Milde, et al.
International Journal of Molecular Sciences
|
May 14, 2020
Myeloproliferative Diseases as Possible Risk Factor for Development of Chronic Thromboembolic Pulmonary Hypertension-A Genetic Study
Christina A Eichstaedt, Jeremias Verweyen, Michael Halank, et al.
Annals of the Rheumatic Diseases
|
December 17, 2020
Response to: ' Correspondence on 'Haemodynamic phenotypes and survival in patients with systemic sclerosis: the impact of the new definition of pulmonary arterial hypertension'' by Iudici <i>et al</i>
Ekkehard Grünig, Nicola Benjamin, Panagiota Xanthouli, et al.
Pneumologie (Stuttgart, Germany)
|
October 6, 2025
[General Measures and Management of PAH in Special Conditions]
Mona Lichtblau, Satenik Harutyunova, Hans Klose, et al.
Arthritis Research & Therapy
|
October 28, 2019
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study)
Zixuan Pan, Alberto M Marra, Nicola Benjamin, et al.
International Journal of Cardiology
|
September 8, 2018
General measures and supportive therapy for pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
Ekkehard Grünig, Nicola Benjamin, Ulrich Krüger, et al.
Page
of 8